Treatment Principles of First-Episode Psychosis

被引:5
作者
Ucok, Alp [1 ]
机构
[1] Istanbul Sch Med, Dept Psychiat, Psychot Disorders Res Program, Istanbul, Turkey
来源
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | 2021年 / 58卷
关键词
First-episode; psychosis; pharmacological treatment; psychosocial treatment; 1ST EPISODE PSYCHOSIS; SCHIZOPHRENIA; ANTIPSYCHOTICS; OLANZAPINE;
D O I
10.29399/npa.27424
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Treatment of first-episode psychosis, which has unique advantages and challenges, has an impact on the course of the illness. On one hand, clinician has to understand triggering factors of psychosis and make differential diagnosis, and on other hand he has to choose a rationale psychopharmacological treatment. Although there is no difference between first generation antipsychotics and second generation antipsychotics in terms of effectiveness, the latter group has advantages in terms of side effects and tolerability. Tolerability issues and particularly metabolic side effects should be taken into account when choosing antipsychotic to treat first episode and beyond. Additionally, psychosocial approaches like family psychoeducation should be combined with pharmacological approaches in early phase of psychosis. Clinicians should monitor the medication adherence in every outpatient visit, and minimum duration of treatment is recommended as three years after remission.
引用
收藏
页码:S12 / S16
页数:5
相关论文
共 26 条
[1]   Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis [J].
Abdel-Baki, Amal ;
Medrano, Sofia ;
Maranda, Catherine ;
Ladouceur, Martin ;
Tahir, Ramzan ;
Stip, Emmanuel ;
Potvin, Stephane .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2020, 35 (04) :221-228
[2]   Preventing the Second Episode: A Systematic Review and Meta-analysis of Psychosocial and Pharmacological Trials in First-Episode psychosis [J].
Alvarez-Jimenez, Mario ;
Parker, Alexandra G. ;
Hetrick, Sarah E. ;
McGorry, Patrick D. ;
Gleeson, John F. .
SCHIZOPHRENIA BULLETIN, 2011, 37 (03) :619-630
[3]  
Baran Z, 2010, J NEUROPSYCH CLIN N, V22, pE13
[4]   The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements [J].
Buchanan, Robert W. ;
Kreyenbuhl, Julie ;
Kelly, Deanna L. ;
Noel, Jason M. ;
Boggs, Douglas L. ;
Fischer, Bernard A. ;
Himelhoch, Seth ;
Fang, Beverly ;
Peterson, Eunice ;
Aquino, Patrick R. ;
Keller, William .
SCHIZOPHRENIA BULLETIN, 2010, 36 (01) :71-93
[5]   The metabolic effects of antipsychotics in the early stage of treatment in first-episode patients with schizophrenia: A real-world study in a naturalistic setting [J].
Cao, Hailing ;
Meng, Yajing ;
Li, Xiaojing ;
Ma, Xiaohong ;
Deng, Wei ;
Guo, Wanjun ;
Li, Tao .
JOURNAL OF PSYCHIATRIC RESEARCH, 2020, 129 :265-271
[6]   Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis [J].
Crossley, Nicolas A. ;
Constante, Miguel ;
McGuire, Philip ;
Power, Paddy .
BRITISH JOURNAL OF PSYCHIATRY, 2010, 196 (06) :434-439
[7]   Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia [J].
Emsley, Robin ;
Asmal, Laila ;
Rubio, Jose M. ;
Correll, Christoph U. ;
Kane, John M. .
SCHIZOPHRENIA RESEARCH, 2020, 225 :55-62
[8]   Psychiatric Presentation of Anti-NMDA Receptor Encephalitis [J].
Endres, Dominique ;
Rauer, Sebastian ;
Kern, Winfried ;
Venhoff, Nils ;
Maier, Simon J. ;
Runge, Kimon ;
Suess, Patrick ;
Feige, Bernd ;
Nickel, Kathrin ;
Heidt, Timo ;
Domschke, Katharina ;
Egger, Karl ;
Pruess, Harald ;
Meyer, Philipp T. ;
van Elst, Ludger Tebartz .
FRONTIERS IN NEUROLOGY, 2019, 10
[9]   Designing a feasible exercise intervention in first-episode psychosis: Exercise quality, engagement and effect [J].
Fisher, Emily ;
Wood, Stephen J. ;
Upthegrove, Rachel ;
Aldred, Sarah .
PSYCHIATRY RESEARCH, 2020, 286
[10]   Focusing on recovery goals improves motivation in first-episode psychosis [J].
Fulford, Daniel ;
Meyer-Kalos, Piper S. ;
Mueser, Kim T. .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2020, 55 (12) :1629-1637